Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
621.90M | 553.50M | 707.60M | 764.70M | 868.10M | 764.30M | Gross Profit |
249.70M | 234.80M | 283.40M | 276.30M | 359.50M | 271.20M | EBIT |
52.50M | 51.80M | 51.10M | 66.20M | 115.80M | 45.30M | EBITDA |
-139.60M | 51.80M | 98.90M | -360.00M | 184.90M | 110.50M | Net Income Common Stockholders |
-240.70M | -239.50M | 72.40M | -430.10M | 150.40M | 2.90M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
101.90M | 130.10M | 87.30M | 48.20M | 68.90M | 147.80M | Total Assets |
1.10B | 1.12B | 1.46B | 1.18B | 1.73B | 1.65B | Total Debt |
209.80M | 213.00M | 286.70M | 60.60M | 96.10M | 194.00M | Net Debt |
107.90M | 82.90M | 199.40M | 12.40M | 27.20M | 46.20M | Total Liabilities |
341.30M | 362.20M | 428.70M | 191.00M | 272.10M | 351.40M | Stockholders Equity |
755.80M | 756.00M | 1.03B | 992.90M | 1.46B | 1.30B |
Cash Flow | Free Cash Flow | ||||
99.90M | 116.50M | 105.50M | 54.20M | 133.50M | 96.20M | Operating Cash Flow |
114.10M | 130.10M | 122.70M | 86.30M | 182.10M | 128.10M | Investing Cash Flow |
37.90M | 45.20M | -141.60M | -32.70M | -129.60M | -35.10M | Financing Cash Flow |
-171.80M | -132.00M | 58.20M | -73.20M | -131.40M | -23.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | $718.36M | 13.01 | 30.02% | 5.52% | 3.73% | 11.24% | |
79 Outperform | $1.23B | 29.47 | 7.30% | ― | -4.47% | 195.28% | |
73 Outperform | $1.01B | 19.76 | 12.45% | ― | 20.53% | -27.75% | |
63 Neutral | $787.23M | 33.64 | 4.78% | ― | -6.97% | ― | |
62 Neutral | $11.97B | 10.29 | -7.47% | 2.99% | 7.32% | -8.06% | |
59 Neutral | $1.49B | ― | -26.83% | ― | -18.14% | -405.65% | |
56 Neutral | $1.71B | ― | -12.00% | ― | 19.02% | 76.67% |
Knowles Corporation announced an investor update meeting scheduled for May 13, 2025, to discuss its business and financial outlook. The company is repositioning its portfolio towards higher-margin products and markets, including MedTech, Defense, and Industrial sectors, and aims for significant revenue and EBITDA growth over the next five years. The strategic shift involves divestitures and acquisitions, enhancing its market position and financial performance, which is expected to create value for stakeholders.
The most recent analyst rating on (KN) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Knowles stock, see the KN Stock Forecast page.